Anti-CD 19 and anti-CD 20 CAR-modified T cells for B-cell malignancies: a systematic review and meta-analysis

Riaz, IB; Zahid, U; Kamal, MU; Husnain, M; McBride, A; Hua, A; Hamadani, AA; George, L; Zeeshan, A; Sipra, QUAR; Raina, A; Rahman, B; Puvvada, S; Anwer, F

Anwer, F (reprint author), Univ Arizona, Dept Med Hematol & Oncol, Tucson, AZ 85724 USA.

IMMUNOTHERAPY, 2017; 9 (12): 979

Abstract

Chimeric antigen receptor modified T cells targeting CD19 and CD20 have shown activity in Phase I, II trials of patients with hematological malignanci......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索